Luzhou Tiansheng Pharmaceutical Co., Ltd. announced that it will receive CNY 150,000,000 in an equity round of funding on February 13, 2018. The transaction will include participation from existing investor Tiansheng Pharmaceutical Group Co., Ltd. (SZSE:002872). On closing, the capital of the company will increase from CNY 50,000,000 to CNY 200,000,000. The investor will retain its 100% stake in the company. The transaction was approved at the 11th session of the 4th directorate of the investor.